1.38BMarket Cap-8094P/E (TTM)
18.260High17.620Low191.34KVolume17.790Open17.840Pre Close3.45MTurnover0.39%Turnover RatioLossP/E (Static)76.63MShares24.17052wk High2.97P/B886.01MFloat Cap8.17052wk Low--Dividend TTM49.09MShs Float43.000Historical High--Div YieldTTM3.59%Amplitude2.500Historical Low18.038Avg Price1Lot Size
Kura Oncology Stock Forum
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology | KURA Stock News
$Kura Oncology (KURA.US)$
No comment yet